Genital human papillomavirus infections: current and prospective therapies

MA Stanley - Journal of general virology, 2012 - microbiologyresearch.org
Infection with human papillomaviruses (HPVs) is very common and associated with benign
and malignant epithelial proliferations of skin and internal squamous mucosae. A subset of …

Human papillomavirus therapeutic vaccines: targeting viral antigens as immunotherapy for precancerous disease and cancer

MP Morrow, J Yan, NY Sardesai - Expert review of vaccines, 2013 - Taylor & Francis
Infections with oncogenic HPV types have the potential to lead to the induction of several
types of cancer, notably cervical, vulvar, anal, and head and neck cancer. While prophylactic …

Immunobiology of HPV and HPV vaccines

M Stanley - Gynecologic oncology, 2008 - Elsevier
Genital human papillomavirus (HPV) infection with both low-and high-risk types is common,
but most infections resolve as a result of a cell-mediated immune response. Failure to …

Emerging human papillomavirus vaccines

ND Christensen - Expert Opinion on Emerging Drugs, 2005 - Taylor & Francis
Human papillomavirus (HPV) infections are a leading cause of virus-associated cancers of
the anogenital, oropharyneal and cutaneous epithelium. The most prevalent of these is …

Immune control of human papillomavirus (HPV) associated anogenital disease and potential for vaccination

PL Stern - Journal of clinical virology, 2005 - Elsevier
This review discusses:(1) immune mechanisms relevant to the natural control of a human
papillomavirus (HPV) infection;(2) viral strategies to evade or subvert immune attack;(3) the …

Therapeutic human papillomavirus vaccines: current clinical trials and future directions

CF Hung, B Ma, A Monie, SW Tsen… - Expert opinion on …, 2008 - Taylor & Francis
Background: Cervical cancer is the second largest cause of cancer deaths in women
worldwide. It is now evident that persistent infection with high-risk human papillomavirus …

The use of both therapeutic and prophylactic vaccines in the therapy of papillomavirus disease

AR Garbuglia, D Lapa, C Sias… - Frontiers in …, 2020 - frontiersin.org
Human papillomavirus (HPV) is the most common sexually transmitted virus. The high-risk
HPV types (ie, HPV16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59) are considered to be the …

Current therapeutic vaccination and immunotherapy strategies for HPV-related diseases

JG Skeate, AW Woodham, MH Einstein… - Human vaccines & …, 2016 - Taylor & Francis
Carcinomas of the anogenital tract, in particular cervical cancer, remains one of the most
common cancers in women, and represent the most frequent gynecological malignancies …

Vaccines against human papillomavirus and cervical cancer: promises and challenges

A Mahdavi, BJ Monk - The Oncologist, 2005 - academic.oup.com
Abstract Learning Objectives After completing this course, the reader will be able to: Discuss
the epidemiology and pathogenesis of HPV and HPV-associated diseases. Explain the …

Current state in the development of candidate therapeutic HPV vaccines

A Yang, J Jeang, K Cheng, T Cheng… - Expert review of …, 2016 - Taylor & Francis
The identification of human papillomavirus (HPV) as an etiological factor for HPV-associated
malignancies creates the opportunity to control these cancers through vaccination …